@ARTICLE{
author={Tiede Andreas,Rosa Cid Ana,Goldmann Georg,Jimenez-Yuste Victor,Pluta Michael,Lissitchkov Toshko,May Marcus,Matytsina Irina,Miljic Predrag S,Pabinger Ingrid,Persson Paula},
year={2020},
title={Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A},
journal={THROMBOSIS AND HAEMOSTASIS},
volume={120},
number={2},
pages={277-288},
document_type={Article},
} 

@ARTICLE{
author={Lentz Steven R,Janic Dragana M,Kavakli Kaan,Miljic Predrag S,Oldenburg Johannes,Ozelo Margareth Castro,Santagostino Elena,Suzuki Takashi,Zupancic-Salek Silva,Korsholm Lars,Matytsina Irina,Tiede Andreas},
year={2018},
title={Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial},
journal={HAEMOPHILIA},
volume={24},
number={6},
pages={E391-E394},
document_type={Article},
} 

@ARTICLE{
author={Lentz SR,Misgav M,Ozelo MC,Salek SZ,Veljkovic Dobrila K,Recht M,Cerqueira MH,Tiede Andreas,Brand B,Mancuso ME,Seremetis S,Lindblom A,Martinowitz U},
year={2013},
title={Results from a large multinational clinical trial (guardian (TM) 1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy},
journal={HAEMOPHILIA},
volume={19},
number={5},
pages={691-697},
document_type={Article},
}